Antonia S - Search Results

1

Sequential oral 9-nitrocamptothecin and etoposide: a pharmacodynamic- and pharmacokinetic-based phase I trial.

Simon GR, Lush RM, Gump J, Tetteh L, Williams C, Cantor A, Antonia S, Garrett C, Rocha-Lima C, Fishman M, Sullivan DM, Munster PN. Simon GR, et al. Among authors: antonia s. Mol Cancer Ther. 2006 Aug;5(8):2130-7. doi: 10.1158/1535-7163.MCT-06-0034. Mol Cancer Ther. 2006. PMID: 16928835 Clinical Trial.

2

Concurrent paclitaxel/cisplatin with thoracic radiation in patients with stage IIIA/B non-small cell carcinoma of the lung.

Antonia SJ, Wagner H, Williams C, Alberts M, Hubbell D, Robinson L, Hilstro J, Ruckdeschel JC. Antonia SJ, et al. Semin Oncol. 1995 Aug;22(4 Suppl 9):34-7. Semin Oncol. 1995. PMID: 7644926 Clinical Trial.

3

Novel therapies for renal cell carcinoma.

Fishman M, Seigne J, Antonia S. Fishman M, et al. Among authors: antonia s. Expert Opin Investig Drugs. 2001 Jun;10(6):1033-44. doi: 10.1517/13543784.10.6.1033. Expert Opin Investig Drugs. 2001. PMID: 11772233 Review.

4

Phase I trial of a B7-1 (CD80) gene modified autologous tumor cell vaccine in combination with systemic interleukin-2 in patients with metastatic renal cell carcinoma.

Antonia SJ, Seigne J, Diaz J, Muro-Cacho C, Extermann M, Farmelo MJ, Friberg M, Alsarraj M, Mahany JJ, Pow-Sang J, Cantor A, Janssen W. Antonia SJ, et al. J Urol. 2002 May;167(5):1995-2000. J Urol. 2002. PMID: 11956426 Clinical Trial.

5

Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection.

Friberg M, Jennings R, Alsarraj M, Dessureault S, Cantor A, Extermann M, Mellor AL, Munn DH, Antonia SJ. Friberg M, et al. Among authors: antonia sj. Int J Cancer. 2002 Sep 10;101(2):151-5. doi: 10.1002/ijc.10645. Int J Cancer. 2002. PMID: 12209992

6

Novel therapies for renal cell carcinoma--an update.

Fishman M, Antonia S. Fishman M, et al. Among authors: antonia s. Expert Opin Investig Drugs. 2003 Apr;12(4):593-609. doi: 10.1517/13543784.12.4.593. Expert Opin Investig Drugs. 2003. PMID: 12665415 Review.

7

Gefitinib (ZD1839) in previously treated advanced non-small-cell lung cancer: experience from a single institution.

Simon GR, Ruckdeschel JC, Williams C, Cantor A, Chiappori A, Rocha Lima CM, Antonia S, Haura E, Wagner H, Robinson L, Sommers E, Alberts M, Bepler G. Simon GR, et al. Among authors: antonia s. Cancer Control. 2003 Sep-Oct;10(5):388-95. doi: 10.1177/107327480301000506. Cancer Control. 2003. PMID: 14581894 Free article. Clinical Trial.

8

Cell-based immune therapy for metastatic renal cancer.

Fishman MN, Antonia SJ. Fishman MN, et al. Expert Rev Anticancer Ther. 2003 Dec;3(6):837-49. doi: 10.1586/14737140.3.6.837. Expert Rev Anticancer Ther. 2003. PMID: 14686706 Review.

9

Specific antitumour vaccine for renal cancer.

Fishman M, Antonia S. Fishman M, et al. Among authors: antonia s. Lancet. 2004 Feb 21;363(9409):583-4. doi: 10.1016/S0140-6736(04)15625-0. Lancet. 2004. PMID: 14987879 No abstract available.

10

Phase II study of first-line sequential chemotherapy with gemcitabine-carboplatin followed by docetaxel in patients with advanced non-small cell lung cancer.

Chiappori A, Simon G, Williams C, Haura E, Rocha-Lima C, Wagner H, Bepler G, Antonia S. Chiappori A, et al. Among authors: antonia s. Oncology. 2005;68(4-6):382-90. doi: 10.1159/000086979. Epub 2005 Jul 12. Oncology. 2005. PMID: 16020967 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

221 results

Search Page

Filters